Allergic rhinitis and impairment issues in schoolchildren: a consensus report

References

• Agency for Healthcare Research and Quality (AHRQ). Management of allergic rhinitis in the working-age population. Washington, DC: AHRQ, 2003. Evidence Report/Technology Assessment No. 67. Available from http://www.ahcpr.gov/clinic/epcsums/rhinworksum.pdf [Accessed 1 April 2004]
   Google Scholar
• Segura T, Casale TB. Allergic rhinitis: basic pathophysiology and therapeutic strategies. Can J Allergy Clin Immunol 1999;4:318–30
   Google Scholar
• Malone DC, Lawson KA, Smith DH, Arrighi HM, Battista C. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99:22–7
   PubMed Web of Science ®Google Scholar
• Skoner DP. Allergic rhinitis: definition, epidemiology, patho-physiology, detection, and diagnosis. J Allergy Clin Immunol 2001;108:S2–8
   PubMed Web of Science ®Google Scholar
• Bender BG, Fischer TJ. Differential impacts of allergic rhinitis and allergy medications on childhood learning. Pediatr Asthma Allergy Immunol 1998;12:1–13
   Google Scholar
• Vuurman EF, van Veggel LM, Uiterwijk MM, Leutner D, O’Hanlon JF. Seasonal allergic rhinitis and antihistamine effects on children’s learning. Ann Allergy 1993;71:121–126
   Google Scholar
• Settipane RA. Complications of allergic rhinitis. Allergy Asthma Proc 1999;20:209–13
   PubMed Web of Science ®Google Scholar
• Richards W. Preventing behavior problems in asthma and allergies. Clin Pediatr 1994;33:617–24
   PubMed Web of Science ®Google Scholar
• The International Study of Asthma and Allergies in Childhood (ISAAC). Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225–32
   Google Scholar
• Strachan D, Sibbald B, Weiland S, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 1997;8:161–76
   PubMed Web of Science ®Google Scholar
• Schoenwetter WF. Allergy rhinitis: epidemiology and natural history. Allergy Asthma Proc 2000;21:1–6
   PubMed Web of Science ®Google Scholar
• American Academy of Family Physicians. Table 36c: Number of office visits (in thousands) by patients age 3 to 17 to selected specialties ranked by the 20 most frequent principal diagnoses by the physician, 2001. Available from http://www.aafp.org/x25059.xml?printxml [Accessed 29 March 2004]
   Google Scholar
• Sly RM. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol 1999;82:233–48
   PubMed Web of Science ®Google Scholar
• Peroni DG, Piacentini GL, Alfonsi L, et al. Rhinitis in pre-school children: prevalence, association with allergic diseases and risk factors. Clin Exp Allergy 2003;33:1349–54
   PubMed Web of Science ®Google Scholar
• Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol 2000;105:S622–7
   PubMed Web of Science ®Google Scholar
• Schoenwetter WF, Dupclay L Jr, Appajosyula S, Botteman MF, Pashos CL. Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin 2004;20:305–17
   PubMed Web of Science ®Google Scholar
• Meltzer EO. Evaluating rhinitis: clinical, rhinomanometric, and cytologic assessments. J Allergy Clin Immunol 1988;82:900–8
   PubMed Web of Science ®Google Scholar
• Jones N. Allergic rhinitis: aetiology, predisposing and risk factors. Rhinology 2004;42:49–56
   PubMed Web of Science ®Google Scholar
• Simons FER. Learning impairment and allergic rhinitis. Allergy Asthma Proc 1996;17:185–9
   PubMed Web of Science ®Google Scholar
• Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994;93:413–23
   Google Scholar
• Marshall PS, Colon EA. Effects of allergy season on mood and cognitive function. Ann Allergy 1993;71:251–8
   PubMedGoogle Scholar
• Craig TJ, Teets S, Lehman EB, Chinchilli VM, Zwillich C. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 1998;101:633–7
   Google Scholar
• Brawley A, Silverman B, Kearney S, et al. Allergic rhinitis in children with attention-deficit/hyperactivity disorder. Ann Allergy Asthma Immunol 2004;92:663–667
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Nathan RA, Selner JC, Storms W. Quality of life and rhinitic symptoms: results of a nationwide survey with the SF-36 and RQLQ questionnaires. J Allergy Clin Immunol 1997;99:S815–9
   Web of Science ®Google Scholar
• Tanner LA, Reilly M, Meltzer EO, Bradford JE, Mason J. Effect of fexofenadine HCL on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis. Am J Managed Care 1999;5(Suppl.):S235–47
   Google Scholar
• Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol 1997;99:S773–80
   Web of Science ®Google Scholar
• Newacheck PW, Stoddard JJ. Prevalence and impact of multiple childhood chronic illnesses. J Pediatr 1994;124:40–8
   PubMed Web of Science ®Google Scholar
• Bachert C, van Cauwenberge P, Khaltaev N, Bousquet J. World Health Organization. Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7–10 December 1999, Geneva, Switzerland. Allergy 2002;57: 841–55
   Google Scholar
• Berrettini S, Carabelli A, Sellari-Franceschini S, et al. Perennial allergic rhinitis and chronic sinusitis: correlation with rhinologic risk factors. Allergy 1999;54:242–8
   Google Scholar
• Fireman P. Therapeutic approaches to allergic rhinitis: treating the child. J Allergy Clin Immunol 2000;105:5616–21
   Google Scholar
• Tomonaga K, Kurono Y, Mogi G. The role of nasal allergy in otitis media with effusion. Acta Otolaryngol 1988;458(Suppl.):41–7
   Google Scholar
• Cohen P, Pine DS, Must A, Kasen S, Brook J. Prospective associations between somatic illness and mental illness from childhood to adulthood. Am J Epidemiol 1998;147:232–9
   Google Scholar
• Arrighi HM, Maier WC, Redding GJ, et al. The impact of allergic rhinitis in Seattle school children [abstract]. J Allergy Clin Immunol 1995;95:192
   Web of Science ®Google Scholar
• Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998;81:478–518
   PubMed Web of Science ®Google Scholar
• Nash DR. Allergic rhinitis. Pediatr Ann 1998;27:799–808
   PubMed Web of Science ®Google Scholar
• Shapiro GG. Understanding allergic rhinitis; differential diagnosis and management. Pediatr Rev 1986;7:212–8
   PubMedGoogle Scholar
• American Academy of Allergy, Asthma, and Immunology. Overview of allergic diseases: diagnosis, management, and barriers to care, in The Allergy Report, Vol. I. Available from http://www.theallergyreport.org
   Google Scholar
• Blaiss M. Current concepts and therapeutic strategies for allergic rhinitis in school-age children. Clin Ther 2004; in press
   Google Scholar
• U.S. Department of Education, Office of Educational Research and Improvement. Condition of America’s Public School Facilities: 1999. Washington, DC; National Center for Education Statistics, 2000
   Google Scholar
• U.S. Environmental Protection Agency. Indoor Air Quality (IAQ) Tools for School. Available from http://www.epa.gov/iaq/schools [Accessed 27 March 2004]
   Google Scholar
• Simons FER, Fraser TG, Reggin JD, Roberts JR, Simons KJ. Adverse central nervous system effects of older antihistamines in children. Pediatr Allergy Immunol 1996;7:22–7
   Google Scholar
• Kemp JP. Special considerations in the treatment of seasonal allergic rhinitis in adolescents: the role of antihistamine therapy. Clin Pediatr 1996;35:383–9
   PubMed Web of Science ®Google Scholar
• Milgrom H, Bender B. Adverse effects of medications for rhinitis. Ann Allergy Asthma Immunol 1997;78:439–46
   PubMed Web of Science ®Google Scholar
• Ten Eick AP, Blumer JL, Reed MD. Safety of antihistamines in children. Drug Safety 2001;24:119–47
   PubMed Web of Science ®Google Scholar
• Meltzer EO. Treatment options for the child with allergic rhinitis. Clin Pediatr 1998;37:1–10
   PubMed Web of Science ®Google Scholar
• Casale TB, Blaiss MS, Gelfand E, et al. First do no harm: managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol 2003;111:S835–42
   PubMed Web of Science ®Google Scholar
• Bousquet J, van Cauwenberge P, Bachert C, et al. Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI); Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy 2003;58:192–7
   Web of Science ®Google Scholar
• Gonzales MA, Estes KS. Pharmacokinetic overview of oral second-generation H1 antihistamines. Int J Clin Pharmaco Ther 1998;36:292–300
   PubMed Web of Science ®Google Scholar
• Welch MJ, Meltzer EO, Simons FER. H1-antihistamines and the central nervous system. Clin Allergy Immunol 2002;17: 337–88
   Google Scholar
• Galant SP, Wilkinson R. Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child: what are the options? Bio Drugs 2001;15:453–463
   Google Scholar
• International Conference on Allergic Rhinitis in Childhood. Allergic rhinitis in childhood. Allergy 1999;54\(Suppl. 55):7–34
   Google Scholar
• Mann RD, Pearce GL, Dunn N, Shakir S. Sedation with ‘nonsedating’ antihistamines: four prescription-event monitoring studies in general practice. BMJ 2000;320:1184–7
   PubMed Web of Science ®Google Scholar
• Zyrtec® (cetirizine hydrochloride) prescribing information. Physicians’ Desk Reference. 58th edn, Montvale, NJ: Thomson PDR; 2004, pp.2696–701
   Google Scholar
• Clarinex® (desloratadine) prescribing information. Physicians’ Desk Reference. 58th edn, Montvale, NJ: Thomson PDR; 2004, pp.3044–6
   Google Scholar
• Claritin® (loratadine) prescribing information. Available from http://www.andrx.com/images/pkg_loratadine.jpg [Accessed November 4 2004]
   Google Scholar
• Astelin® (azelastine hydrochloride) prescribing information. Available from http://www.astelin.com/pi.html. Accessed November 4, 2004
   Google Scholar
• Allegra® (fexofenadine) prescribing information. Physicians’ Desk Reference. 58th edn, Montvale, NJ: Thomson PDR; 2004, pp.713–6
   Google Scholar
• Ng KH, Chong D, Wong CK, et al. Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study. Pediatrics 2004;113:116–21
   Web of Science ®Google Scholar
• Hindmarch I, Shamsi Z. Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side effects. Clin Experimental Allergy 1999;29\(Suppl. 3):133–42
   Google Scholar
• Shields BJ, Cohen DM, Harbeck-Weber C, Powers JD, Smith GA. Pediatric pain measurement using a visual analogue scale: a comparison of two teaching methods. Clin Pediatr 2003;42:227–34
   Google Scholar
• Reilly MC, Tanner A, Meltzer EO. Work, classroom and activity impairment instruments: validation studies in allergic rhinitis. Clin Drug Invest 1996;11:278–88
   Google Scholar
• Fireman P. Rhinitis and asthma connection: management of coexisting upper airway allergic diseases and asthma. Allergy Asthma Proc 2000;21:45–53
   PubMed Web of Science ®Google Scholar
• Schenkel EJ. Pediatric issues relating to the pharmacotherapy of allergic rhinitis. Exp Opin Pharmacother 2000;1:1289–306
   PubMedGoogle Scholar
• Allen DB, Meltzer EO, Lemanske RF Jr, Philpot EE, Faris MA, Kral KM. No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc 2002;23:407–13
   PubMed Web of Science ®Google Scholar
• Schenkel EJ, Skoner DP, Bronsky EA, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000;105:1–7
   PubMed Web of Science ®Google Scholar
• Skoner DP, Rachelefsky GS, Meltzer EO, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000;105:E23
   PubMed Web of Science ®Google Scholar
• Mometasone prescribing information. Physicians’ Desk Reference. 58th edn, Montvale, NJ: Thomson PDR; 2004, pp.1502
   Google Scholar
• Fluticasone prescribing information. Physicians’ Desk Reference. 58th edn, Montvale, NJ: Thomson PDR; 2004, pp.1740
   Google Scholar
• Beclomethasone, budesonide, triamcinolone, and flunisolide prescribing information. Physicians’ Desk Reference. 58th edn, Montvale, NJ: Thomson PDR; 2004, pp.645,1461
   Google Scholar
• Nathan RA. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments. Ann Allergy Asthma Immunol 2003;90:182–91
   PubMed Web of Science ®Google Scholar
• Nayak AS, Philip G, Lu S, et al. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol 2002;88:592–600
   PubMed Web of Science ®Google Scholar
• Philip G, Malmstrom K, Hampel FC Jr, et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Experimental Allergy 2002;32:1020–8
   PubMed Web of Science ®Google Scholar
• Singulair® (montelukast) prescribing information. Available from http://www.singulair.com/singulair/shared/documents/english/singulair_prescribing_info.pdf [Accessed 1 April 2004]
   Google Scholar
• Atrovent® (ipratropium bromide) prescribing information. Ridgefield, CT; Boehringer Ingelheim International GmbH; 2002
   Google Scholar
• Bousquet J, Lockey R, Malling HJ, et al. Allergen immuno-therapy: therapeutic vaccines for allergic diseases. Ann Allergy Asthma Immunol 1998;81:401–5
   PubMed Web of Science ®Google Scholar